Crescent Biopharma Inc.
CBIO | NASDAQ
$12.75
-$0.73 (-5.42%)
Nov 2, 2026, 2:11 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 171.59M | 189.16M | 213.19M | 133.27M | 152.65M | 5.61M | 10.72M | 14.39M | 22.39M | 31.28M | 41.79M | 49.41M | 58.04M | 65M | 47.87M | 51.62M | 60.24M | 76.52M | 90.25M | 101.92M | 118.85M | 132.47M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.61M | 1.27M | 1.32M | 1.36M | 1.41M | n/a | n/a | 52.32K | 137.11K | 339.26K | 757.91K | 102.32K | 102.32K | 102.32K | 344.71K | 860.12K | 2.27M | 2.27M | 1.61M | 1.61M | 1.61M | 1.61M |
Receivables | n/a | n/a | 18M | n/a | n/a | n/a | 136.58K | 50.26K | 76.71K | 109.95K | 175.82K | 188.95K | 215.37K | 234.11K | 144.02K | 90.33K | 120.87K | 4.78K | 1.35K | 1.44K | 1.66K | 444.57K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.17M | 1.37M | 1.28M | 1.3M | 1.58M | 78.76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 179.01M | 195.56M | 236.66M | 134.56M | 154.23M | 5.99M | 11.09M | 15.65M | 23.86M | 33.27M | 43.79M | 52.01M | 60.37M | 68.09M | 50.71M | 53.85M | 61.26M | 77.46M | 90.79M | 104.13M | 120.31M | 133.71M |
Property-Plant & Equipment | 2.15M | 2.3M | 2.32M | 2.35M | 1.8M | n/a | n/a | n/a | 424.21K | 598.26K | 767.83K | 1.09M | 1.35M | 732.8K | 751.17K | 1.25M | 1.51M | 1.73M | 1.95M | 2.2M | 2.45M | 2.7M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.75M | 3.57M | 3.64M | 3.71M | 3.21M | n/a | n/a | 52.32K | 561.31K | 937.52K | 1.53M | 1.19M | 1.45M | 835.12K | 1.1M | 2.11M | 3.78M | 4M | 3.56M | 3.81M | 4.06M | 4.31M |
Total Assets | 182.76M | 199.13M | 240.29M | 138.27M | 157.43M | 5.99M | 11.09M | 15.7M | 24.42M | 34.2M | 45.32M | 53.2M | 61.82M | 68.92M | 51.81M | 55.96M | 65.04M | 81.46M | 94.35M | 107.94M | 124.38M | 138.02M |
Account Payables | 2.54M | 1.19M | 10M | 2.56M | 1.65M | 148.26K | 1.38M | 1.01M | 950.76K | 755.53K | 868.12K | 329.89K | 241.49K | 480.15K | 970.19K | 852.13K | 1.27M | 2.28M | 2.11M | 1.39M | 1.17M | 2.14M |
Deferred Revenue | 3.12M | 3.12M | 4.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.37M | 6.82M | 10.12M | 4.84M | 3.66M | 1.68M | 3.49M | 1.82M | 545.55K | 1.23M | 2.96M | 2.4M | 2.57M | 2M | 2.97M | 2.16M | 2.4M | 1.62M | 2.5M | 2.34M | 2.79M | 2.08M |
Total Current Liabilities | 18.54M | 14.19M | 36.07M | 20.3M | 16.75M | 2.62M | 5.78M | 4.32M | 4.36M | 5.29M | 6.84M | 6.39M | 6.57M | 6.74M | 8.88M | 7.75M | 8.94M | 12.78M | 11.82M | 9.66M | 10.25M | 10.84M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 538.59K | 408.32K | 373.91K |
Total Long-Term Liabilities | 966K | 1.09M | 1.21M | 1.32M | 1.43M | n/a | n/a | n/a | n/a | n/a | 66.84K | 262.13K | 448.78K | n/a | n/a | 95.61K | 378.79K | 651.79K | 918.61K | 1.72M | 1.84M | 2.05M |
Total Liabilities | 19.5M | 15.28M | 37.28M | 21.63M | 18.18M | 2.62M | 5.78M | 4.32M | 4.36M | 5.29M | 6.9M | 6.65M | 7.02M | 6.74M | 8.88M | 7.84M | 9.32M | 13.43M | 12.74M | 11.38M | 12.09M | 12.9M |
Total Debt | 1.44M | 1.54M | 1.64M | 1.74M | 1.64M | n/a | 66.84K | 262.13K | 448.78K | 630.83K | 808.4K | 1.01M | 1.27M | 651.73K | 918.56K | 1.18M | 1.43M | 1.68M | 1.92M | 2.15M | 2.38M | 2.6M |
Book Value | 163.26M | 183.85M | 203.01M | 116.64M | 139.25M | 3.38M | 5.31M | 11.38M | 20.06M | 28.91M | 38.41M | 46.55M | 54.8M | 62.18M | 42.93M | 48.12M | 55.73M | 68.03M | 81.6M | 96.57M | 112.29M | 125.12M |
Book Value Per Share | 5.35 | 6.05 | 10.06 | 7.05 | 36.10 | 4.37 | 8.24 | 17.64 | 31.11 | 44.85 | 59.66 | 72.34 | 85.26 | 103.03 | 81.06 | 91.79 | 106.34 | 130 | 156.89 | 187.27 | 217.87 | 246.81 |
Common Stock | 28K | 28K | 28K | 14K | 14K | 64.53K | 64.48K | 64.48K | 64.48K | 64.45K | 64.39K | 64.37K | 64.31K | 64.25K | 54.38K | 52.42K | 52.42K | 52.39K | 52.31K | 51.74K | 51.54K | 51.54K |
Retained Earnings | -219.93M | -195.09M | -171.81M | -79.41M | -54.81M | -496.71M | -494.36M | -487.14M | -477.32M | -467.22M | -456.49M | -447.41M | -438.2M | -429.95M | -419.59M | -409.34M | -400.82M | -387.55M | -372.9M | -355.48M | -338.14M | -323.74M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 163.26M | 183.85M | 203.01M | 116.64M | 139.25M | 3.38M | 5.31M | 11.38M | 20.06M | 28.91M | 38.41M | 46.55M | 54.8M | 62.18M | 42.93M | 48.12M | 55.73M | 68.03M | 81.6M | 96.57M | 112.29M | 125.12M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CBIO